In furtherance to the intimation captioned "US FDA Inspection at Alkem's manufacturing facility located at Indore" dated 07th July, 2022, this is to inform you that US FDA has issued an Establishment Inspection Report (EIR) for the Company's manufacturing facility located at Indore which was inspected from 01st July, 2022 to 07th July, 2022. In response to Form 483 issued by the US FDA containing one observation, the Company had submitted a detailed corrective and preventive action (CAPA) plan to the regulator within the stipulated timelines. The inspection has now been closed by the US FDA. Kindly take the same on record.